{ "cik": 1826667, "cik_padded": "0001826667", "entityName": "TriSalus Life Sciences, Inc.", "fiscal_years": [ { "accn": "0001628280-26-015163", "filed": "2026-03-05", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 918000.0, "cash": 20439000.0, "cost_of_revenue": 6965000.0, "eps_diluted": -1.84, "free_cash_flow": -18930000.0, "gross_profit": 38186000.0, "net_income": -39227000.0, "operating_cash_flow": -18012000.0, "operating_income": -26946000.0, "revenue": 45151000.0, "stockholders_equity": -33861000.0, "total_assets": 35331000.0, "total_liabilities": 69192000.0 }, "period_end": "2025-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8457398507231291, "net_margin": -0.8687958184757812, "operating_margin": -0.5967974131248477, "revenue_growth_yoy": 0.5341306785362373, "roa_avg2y": -1.322957067215271, "roa_period_end": -1.1102714330191616, "roe_avg2y": 1.3129277884695842 } }, { "accn": "0001628280-26-015163", "filed": "2026-03-05", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 345000.0, "cash": 8525000.0, "cost_of_revenue": 4103000.0, "eps_diluted": -1.31, "free_cash_flow": -41188000.0, "gross_profit": 25328000.0, "net_income": -30045000.0, "operating_cash_flow": -40843000.0, "operating_income": -36165000.0, "revenue": 29431000.0, "stockholders_equity": -25894000.0, "total_assets": 23971000.0, "total_liabilities": 49865000.0 }, "period_end": "2024-12-31", "ratio_units": { "gross_margin": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8605891746797595, "net_margin": -1.0208623560191634, "operating_margin": -1.2288063606401414, "revenue_growth_yoy": 0.5899195073199719, "roa_avg2y": -1.2372089192694928, "roa_period_end": -1.2533895123273957, "roe_avg2y": 1.1346513340508695 } }, { "accn": "0001628280-26-015163", "filed": "2026-03-05", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 588000.0, "cash": 11777000.0, "cost_of_revenue": 2605000.0, "eps_diluted": -6.77, "free_cash_flow": -51166000.0, "gross_profit": 15906000.0, "net_income": -59363000.0, "operating_cash_flow": -50578000.0, "operating_income": -54475000.0, "revenue": 18511000.0, "stockholders_equity": -27065000.0, "total_assets": 24598000.0, "total_liabilities": 51663000.0 }, "period_end": "2023-12-31", "ratio_units": { "gross_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8592728647831019, "revenue_growth_yoy": 0.4930633973221487, "roa_avg2y": -2.54815100980834, "roe_avg2y": 0.5814287183455192 } }, { "accn": "0001826667-25-000070", "filed": "2025-05-30", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "cost_of_revenue": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "gross_profit": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 655000.0, "cash": 9414000.0, "cost_of_revenue": 2258000.0, "eps_diluted": -161.55, "free_cash_flow": -32968000.0, "gross_profit": 10140000.0, "net_income": -47187000.0, "operating_cash_flow": -32313000.0, "operating_income": -36439000.0, "revenue": 12398000.0, "stockholders_equity": -177132000.0, "total_assets": 21995000.0, "total_liabilities": 34319000.0 }, "period_end": "2022-12-31", "ratio_units": { "gross_margin": "ratio", "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "gross_margin": 0.8178738506210679, "roa_avg2y": -0.34629079585931555, "roe_avg2y": 0.30767074073228856 } }, { "accn": "0001826667-24-000005", "filed": "2024-04-11", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 200884.0, "net_income": 4767283.0, "operating_cash_flow": -1738114.0, "operating_income": -3040714.0, "stockholders_equity": -129605000.0, "total_assets": 250533179.0, "total_liabilities": 17250282.0 }, "period_end": "2021-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": 0.018972573930864954, "roa_period_end": 0.01902854950800748, "roe_avg2y": -0.06310546526411856 } }, { "accn": "0001410578-22-000252", "filed": "2022-03-03", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 1334998.0, "stockholders_equity": -21484386.0, "total_assets": 252011496.0, "total_liabilities": 23495882.0 }, "period_end": "2020-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001628280-26-015163", "filed": "2026-03-05", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "3841", "sic_description": "Surgical & Medical Instruments & Apparatus", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001826667.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001826667.json" }, "ticker": "TLSI" }